Last reviewed · How we verify
NCT03980600: FibDexHBC
NFC Dressing for Skin Graft Donor Sites
NA trial testing FibDex wound dressing in Skin Transplantation in 33 participants. Completed in 19 September 2018.
8 January 2018
Quick facts
| Lead sponsor | UPM-Kymmene Corporation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 33 |
| Start date | 16 February 2015 |
| Primary completion | 8 January 2018 |
| Estimated completion | 19 September 2018 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- FibDex wound dressing
- NFC wound dressing Types 1-3
- Suprathel (comparator)
Conditions studied
- Skin Transplantation — all drugs for Skin Transplantation →
Sponsor
UPM-Kymmene Corporation
Who can join
Adults 18 to 75, any sex, with Skin Transplantation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this single center clinical investigation was to optimize nanofibrillar cellulose (NFC) wound dressing and to investigate final product FibDex in the treatment of split thickness skin graft donor sites. Performance of NFC dressings Type 1, Type 2, Type 3 and Type 4 (final product, FibDex) was compared with that of Suprathel®.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
An overview to nanocellulose clinical application: Biocompatibility and opportunities in disease treatment.
Malekpour K, Hazrati A, Khosrojerdi A, Roshangar L, et al · · 2023 · cited 11× · PMID 38034858 · DOI 10.1016/j.reth.2023.10.006 -
Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148
Verify or expand the search:
- PubMed search for NCT03980600
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Transplantation
Currently open trials in the same condition.
- NCT07057557 — Aloe Vera vs Paraffin Tulle Dressings for Pain Management in Split Thickness Skin Graft Donor Sites · NA · recruiting
Other UPM-Kymmene Corporation trials
Trials by the same sponsor.
- NCT05629091 — An Investigation of Performance and Safety of the Wound Dressing FibDex in Patients With Superficial Dermal Burns · NA · terminated
- NCT05666999 — Post-market Clinical Follow-up Study for a CE Marked Wound Care Product (FibDex®) · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03980600 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by UPM-Kymmene Corporation
- Last refreshed: 10 June 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03980600.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing